Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Hawkins
HWKN
$2.7B
| $833K | ﹤0.01% |
+19,039
| New | +$770K |
|
1727
Beam Therapeutics
BEAM
$2.76B
| $833K | ﹤0.01% |
27,229
+13,650
| +101% | +$539K |
|
1728
Park National Corp
PRK
$3.72B
| $832K | ﹤0.01% |
7,044
+3,902
| +124% | +$499K |
|
|
ELME
1729
Elme Communities
ELME
$144M
| $831K | ﹤0.01% |
46,561
+29,370
| +171% | +$538K |
|
1730
Banner Corp
BANR
$2.5B
| $831K | ﹤0.01% |
15,288
+8,156
| +114% | +$498K |
|
1731
Pathward Financial
CASH
$1.78B
| $828K | ﹤0.01% |
19,965
+9,184
| +85% | +$433K |
|
1732
Lennox International
LII
$14.5B
| $827K | ﹤0.01% |
3,291
-1
| -0% | -$252 |
|
1733
Fastly Inc
FSLY
$4.54B
| $827K | ﹤0.01% |
46,562
+26,727
| +135% | +$340K |
|
1734
Green Plains
GPRE
$1.06B
| $826K | ﹤0.01% |
26,676
+14,131
| +113% | +$461K |
|
1735
Riot Platforms
RIOT
$7.63B
| $825K | ﹤0.01% |
82,717
+59,832
| +261% | +$389K |
|
1736
Alaska Air
ALK
$5.29B
| $824K | ﹤0.01% |
19,648
+14,710
| +298% | +$690K |
|
1737
CorVel
CRVL
$3.17B
| $816K | ﹤0.01% |
12,873
+6,891
| +115% | +$403K |
|
1738
Granite Construction
GVA
$5.52B
| $813K | ﹤0.01% |
19,804
+10,528
| +113% | +$429K |
|
1739
Cohu
COHU
$2.66B
| $811K | ﹤0.01% |
21,134
-17,691
| -46% | -$640K |
|
1740
A.O. Smith
AOS
$8.51B
| $808K | ﹤0.01% |
11,690
+5,918
| +103% | +$385K |
|
1741
Pacira BioSciences
PCRX
$945M
| $808K | ﹤0.01% |
19,807
+10,976
| +124% | +$437K |
|
1742
Sylvamo
SLVM
$1.53B
| $808K | ﹤0.01% |
17,465
+9,586
| +122% | +$455K |
|
|
BACA
1743
DELISTED
Berenson Acquisition Corp. I
BACA
| $806K | ﹤0.01% |
80,000
-164
| -0.2% | -$1.66K |
|
|
VRTV
1744
DELISTED
VERITIV CORPORATION
VRTV
| $803K | ﹤0.01% |
5,940
+3,251
| +121% | +$416K |
|
1745
InvenTrust Properties
IVT
$2.59B
| $802K | ﹤0.01% |
34,297
+21,386
| +166% | +$505K |
|
1746
Bumble
BMBL
$344M
| $799K | ﹤0.01% |
40,869
-27,463
| -40% | -$620K |
|
1747
AtriCure
ATRC
$2.22B
| $799K | ﹤0.01% |
19,275
+10,571
| +121% | +$439K |
|
1748
ACM Research
ACMR
$5.66B
| $799K | ﹤0.01% |
68,279
+27,283
| +67% | +$316K |
|
|
JWN
1749
DELISTED
Nordstrom
JWN
| $798K | ﹤0.01% |
49,074
+26,637
| +119% | +$498K |
|
1750
First Financial Bancorp
FFBC
$3.58B
| $797K | ﹤0.01% |
36,629
+18,845
| +106% | +$452K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.